SignalDailyGlobal signals. Global context.

Market Incident

Public · Developing

AI compiled from Infoway · 8 analyzed stories

Revvity, Inc. (RVTY) Reports Pro Forma Adjusted EPS of $1.37, Up From $1.13

Revvity reported third-quarter pro forma adjusted earnings per share of $1.37, up from $1.13 a year earlier, and pro forma revenue of $710 million versus $660 million. It also issued full-year pro forma guidance of about $2.86 billion in revenue, roughly 5% organic growth, and adjusted earnings per share of $5.40 to $5.45.

Published:

Updated:

What happened

Revvity reported third-quarter organic growth of 7%, with strength in Life Sciences and improving demand from pharmaceutical and biotech customers. It also reported adjusted earnings per share of $1.37 and raised its full-year growth guidance to about 5%.

Global impact / market context

Faster growth and higher guidance may suggest demand is improving, which can support investor confidence. But the reports do not show how the market reacted, and future results are not assured.

What to watch

  1. Check whether Revvity reports continued strength in Life Sciences, since that business led third-quarter growth.
  2. Check whether pharmaceutical and biotech demand keeps improving, as these customers helped support growth.
  3. Check whether Revvity meets its full-year target of about 5% organic growth, since it raised its guidance to that level.

Affected assets

  • Revvity, Inc.

Evidence